Developing a Multimodal Model for Detecting Higher-Grade Prostate Cancer Using Biomarkers and Risk Factors.
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2022
2022
Historique:
received:
31
03
2022
revised:
02
05
2022
accepted:
13
05
2022
entrez:
20
6
2022
pubmed:
21
6
2022
medline:
22
6
2022
Statut:
epublish
Résumé
A technique to predict crucial clinical prostate cancer (PC) is desperately required to prevent diagnostic errors and overdiagnosis. To create a multimodal model that incorporates long-established messenger RNA (mRNA) indicators and conventional risk variables for identifying individuals with severe PC on prostatic biopsies. Urinary has gathered for mRNA analysis following a DRE and before a prostatic examination in two prospective multimodal investigations. A first group (
Identifiants
pubmed: 35722463
doi: 10.1155/2022/9223400
pmc: PMC9205705
doi:
Substances chimiques
Biomarkers, Tumor
0
RNA, Messenger
0
Prostate-Specific Antigen
EC 3.4.21.77
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
9223400Informations de copyright
Copyright © 2022 Palanivel Velmurugan et al.
Déclaration de conflit d'intérêts
All authors declare that they have no conflicts of interest.
Références
World J Oncol. 2019 Apr;10(2):63-89
pubmed: 31068988
Clin Cancer Res. 2015 Jul 1;21(13):3061-70
pubmed: 25788493
Eur Urol Oncol. 2020 Oct;3(5):582-593
pubmed: 32891600
Cold Spring Harb Perspect Med. 2018 Dec 3;8(12):
pubmed: 29311132
Radiology. 1999 Nov;213(2):481-8
pubmed: 10551230
Genes Dev. 2000 Oct 1;14(19):2410-34
pubmed: 11018010
Science. 1996 Nov 22;274(5291):1371-4
pubmed: 8910276
Sci Rep. 2015 Mar 04;5:8758
pubmed: 25737022
Curr Urol Rep. 2012 Dec;13(6):447-54
pubmed: 22935886
Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):887-906
pubmed: 27197278
Sci Transl Med. 2012 Mar 28;4(127):127rv3
pubmed: 22461644
Clin Cancer Res. 2006 Sep 15;12(18):5423-34
pubmed: 17000676
J Urol. 2003 Jul;170(1):313-4
pubmed: 14567302
BJU Int. 2016 Mar;117(3):401-8
pubmed: 26332503
Can Urol Assoc J. 2019 May;13(5):E145-E150
pubmed: 30332595
Prostate. 2015 Mar 1;75(4):390-8
pubmed: 25408531
Semin Oncol Nurs. 2011 Nov;27(4):241-50
pubmed: 22018403
Nat Rev Urol. 2011 Apr 26;8(6):312-20
pubmed: 21519351
BMJ. 1994 Jul 9;309(6947):102
pubmed: 8038641
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
J Urol. 2012 Nov;188(5):1726-31
pubmed: 22998901
Prostate Int. 2019 Mar;7(1):1-8
pubmed: 30937291
Genes Dev. 2018 Jul 1;32(13-14):868-902
pubmed: 29945886
J Urol. 1997 Apr;157(4):1315-21
pubmed: 9120930
Clin Chem. 2006 Jun;52(6):1089-95
pubmed: 16627561
Prostate Cancer Prostatic Dis. 2019 Mar;22(1):91-100
pubmed: 30108373
Dtsch Arztebl Int. 2021 Apr 02;118(Forthcoming):
pubmed: 33549154
Biochim Biophys Acta Mol Cell Res. 2018 Dec;1865(12):1857-1868
pubmed: 30262433